Pharmacology & Pharmacy Journals

NR

Nature Reviews Drug Discovery

NATURE PORTFOLIO

IF: 101.8

Q1

Hybrid

Pharmacology

IF: 101.8

Q1

Hybrid

DR

Drug Resistance Updates

Elsevier BV

IF: 21.7

Q1

Hybrid

Pharmacology

IF: 21.7

Q1

Hybrid

TI

Trends In Pharmacological Sciences

Elsevier BV

IF: 19.9

Q1

Hybrid

Pharmacology

IF: 19.9

Q1

Hybrid

AD

Advanced Drug Delivery Reviews

Elsevier BV

IF: 17.6

Q1

Hybrid

Pharmacology

IF: 17.6

Q1

Hybrid

PR

Pharmacological Reviews

American Society for Pharmacology and Experimental Therapeutics

IF: 17.3

Q1

Hybrid

Pharmacology

IF: 17.3

Q1

Hybrid

AP

Acta Pharmaceutica Sinica B

Elsevier BV

IF: 14.6

Q1

Open

Pharmacology

IF: 14.6

Q1

Open

Dr

Drugs

Adis, Springer Healthcare

IF: 14.4

Q1

Hybrid

Pharmacology

Toxicology

IF: 14.4

Q1

Hybrid

AR

Annual Review Of Pharmacology And Toxicology

ANNUAL REVIEWS

IF: 13.1

Q1

Open

Pharmacology

Toxicology

IF: 13.1

Q1

Open

P&

Pharmacology & Therapeutics

Elsevier BV

IF: 12.5

Q1

Hybrid

Pharmacology

IF: 12.5

Q1

Hybrid

AJ

Asian Journal Of Pharmaceutical Sciences

Elsevier BV

IF: 11.9

Q1

Hybrid

Pharmacology

IF: 11.9

Q1

Hybrid

MR

Medicinal Research Reviews

WILEY

IF: 11.6

Q1

Hybrid

Pharmacology

IF: 11.6

Q1

Hybrid

JO

Journal Of Controlled Release

Elsevier BV

IF: 11.5

Q1

Hybrid

Pharmacology

IF: 11.5

Q1

Hybrid

PR

Pharmacological Research

Elsevier BV

IF: 10.5

Q1

Open

Pharmacology

IF: 10.5

Q1

Open

JO

Journal Of Pharmaceutical Analysis

Elsevier BV

IF: 8.9

Q1

Open

Pharmacology

IF: 8.9

Q1

Open

AP

Acta Pharmacologica Sinica

Springer Nature

IF: 8.4

Q1

Hybrid

Pharmacology

IF: 8.4

Q1

Hybrid

Ph

Phytomedicine

Elsevier BV

IF: 8.3

Q1

Hybrid

Integrative

Pharmacology

IF: 8.3

Q1

Hybrid

DD

Drug Delivery

Taylor & Francis

IF: 8.1

Q1

Hybrid

Pharmacology

IF: 8.1

Q1

Hybrid

DD

Drug Discovery Today

Elsevier BV

IF: 7.5

Q1

Hybrid

Pharmacology

IF: 7.5

Q1

Hybrid

CD

Cns Drugs

Adis, Springer Healthcare

IF: 7.4

Q1

Hybrid

Neurology

Pharmacology

Psychiatry

IF: 7.4

Q1

Hybrid

Ne

Neuropsychopharmacology

Springer Nature

IF: 7.1

Q1

Hybrid

Neurosciences

Pharmacology

Psychiatry

IF: 7.1

Q1

Hybrid

Ne

Neurotherapeutics

Springer Science+Business Media

IF: 6.9

Q1

Open

Neurology

Neurosciences

Pharmacology

IF: 6.9

Q1

Open

Bi

Biodrugs

Adis, Springer Healthcare

IF: 6.9

Q1

Hybrid

Immunology

Oncology

Pharmacology

IF: 6.9

Q1

Hybrid

AP

Alimentary Pharmacology & Therapeutics

WILEY

IF: 6.7

Q1

Hybrid

Gastroenterology

Pharmacology

IF: 6.7

Q1

Hybrid

CM

Chinese Medicine

BioMed Central

IF: 5.7

Q1

Open

Integrative

Pharmacology

IF: 5.7

Q1

Open

JO

Journal Of Ethnopharmacology

Elsevier BV

IF: 5.4

Q1

Hybrid

Integrative

Pharmacology

IF: 5.4

Q1

Hybrid

CJ

Chinese Journal Of Natural Medicines

Elsevier BV

IF: 4.9

Q1

Open

Integrative

Pharmacology

IF: 4.9

Q1

Open

PB

Pharmaceutical Biology

Taylor & Francis

IF: 4.8

Q1

Open

Laboratory

Pharmacology

IF: 4.8

Q1

Open

IJ

International Journal Of Antimicrobial Agents

Elsevier BV

IF: 4.6

Q1

Hybrid

Infectious

Pharmacology

IF: 4.6

Q1

Hybrid

Ph

Pharmacoeconomics

Adis, Springer Healthcare

IF: 4.6

Q1

Hybrid

Healthcare

Policy

Pharmacology

IF: 4.6

Q1

Hybrid

An

Antibiotics-basel

Multidisciplinary Digital Publishing Institute

IF: 4.6

Q1

Open

Infectious

Pharmacology

IF: 4.6

Q1

Open

MD

Molecular Diagnosis & Therapy

Adis, Springer Healthcare

IF: 4.4

Q1

Hybrid

Genetics

Pharmacology

IF: 4.4

Q1

Hybrid

ER

Expert Review Of Anti-infective Therapy

Taylor & Francis

IF: 3.8

Q1

Hybrid

Infectious

Pharmacology

IF: 3.8

Q1

Hybrid

JO

Journal Of Antimicrobial Chemotherapy

Oxford University Press

IF: 3.6

Q2

Hybrid

Infectious

Pharmacology

IF: 3.6

Q2

Hybrid

JR

Jac-antimicrobial Resistance

Oxford University Press

IF: 3.3

Q2

Open

Infectious

Pharmacology

IF: 3.3

Q2

Open

JO

Journal Of Global Antimicrobial Resistance

Elsevier BV

IF: 3.2

Q2

Open

Infectious

Pharmacology

IF: 3.2

Q2

Open

IA

Infection And Drug Resistance

Dove Medical Press

IF: 2.9

Q2

Open

Infectious

Pharmacology

IF: 2.9

Q2

Open

PP

Pulmonary Pharmacology & Therapeutics

Elsevier BV

IF: 2.8

Q2

Hybrid

Pharmacology

Respiratory

IF: 2.8

Q2

Hybrid

JO

Journal Of Pharmaceutical Policy And Practice

BioMed Central

IF: 2.5

Q2

Open

Policy

Pharmacology

IF: 2.5

Q2

Open

PB

Pharmacology Biochemistry And Behavior

Elsevier BV

IF: 2.5

Q2

Hybrid

Behavioral

Neurosciences

Pharmacology

IF: 2.5

Q2

Hybrid

AT

Antiviral Therapy

SAGE Publishing

IF: 2.3

Q3

Open

Infectious

Pharmacology

Virology

IF: 2.3

Q3

Open

HR

Hiv Research & Clinical Practice

Taylor & Francis

IF: 1.8

Q3

Open

Infectious

Pharmacology

IF: 1.8

Q3

Open

JO

Journal Of Chemotherapy

Taylor & Francis

IF: 1.8

Q3

Hybrid

Infectious

Oncology

Pharmacology

IF: 1.8

Q3

Hybrid

JO

Journal Of Infection And Chemotherapy

Elsevier BV

IF: 1.5

Q4

Hybrid

Infectious

Pharmacology

IF: 1.5

Q4

Hybrid